| ²é¿´: 1961 | »Ø¸´: 22 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
ÕâÑùµÄÉó¸åÒâ¼û£¬ÎÒµÄÎÄÕÂÔõô·¢ÄØ£¿
|
|||
|
È¥ÄêÉó¸åÒâ¼û»ØÀ´ÁË£¬µ±Ê±ÎÒ¾ÍÕð¾ªÁË£¬Ò²Óеã»ÒÐÄ¡£¡£¡£¡£¡£ ½ñÄ껹ÊǵÃÊÕʰ£¬Çë´ó¼Ò°ïÎÒ¿´¿´Õâ¸öÉó¸åÒâ¼û. ÎÒÏë¼ÌÐø·¢Õâ¸öµµ´ÎµÄÓеãÎÊÌ⣬·¢µÍÒ»µãµÄÐв»£¿ÏÖÔÚÒ²²»¿ÉÄܲ¹ÊµÑéÁË£¬Ö»ÄÜÔÚд·¨ÉÏÐÞ¸ÄÁË¡£ Dear Dr., Thank you very much for submitting your above-mentioned manuscript for review to ####. After careful consideration, we have decided that your manuscript does not meet one or several of our criteria and must be rejected for publication. Specifically, I agree with the reviewer that the results you present are too preliminary to warrant publication at this stage. Unfortunately, due to the concerns described above, we cannot accept a revised version of your manuscript. I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision. Yours sincerely, ......................................................................................... Reviewers' comments: Much is needed to be improved for this study before ready for manuscript review. First, as it is written as a methods development, at least one target gene needs to be illustrate. There are no details on methodology either. Throughout the manuscript, there is not description of this gene? There is one published paper on this, another one referred to as submitted to Plos1. What is this gene? It is up to the author to explain, not the reviewer to find out through references. Why only 2 out of 6 used were effective? There is no explanation at all. |
» ²ÂÄãϲ»¶
299Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸±±¾©Àí¹¤´óѧ±¾¿Æ211²ÄÁϹ¤³Ì294Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
300Çóµ÷¼Á£¬²ÄÁÏ¿ÆÑ§Ó¢Ò»Êý¶þ
ÒѾÓÐ8È˻ظ´
ÕÐÊÕÉúÎïѧ/ϸ°ûÉúÎïѧµ÷¼Á
ÒѾÓÐ5È˻ظ´
070305¸ß·Ö×Ó»¯Ñ§ÓëÎïÀí 304·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
289Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ²ÄÁÏÓ뻯¹¤·½Ïò336·Ö
ÒѾÓÐ9È˻ظ´
081200-11408-276ѧ˶Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
µ÷¼ÁÇóԺУÕÐÊÕ
ÒѾÓÐ5È˻ظ´
µ÷¼Á310
ÒѾÓÐ8È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ĿǰһƪSCIÂÛÎÄÕýÔÚÉó¸åÖУ¬µ«ÏÖÔÚ·¢ÏÖÁËÎÄÕÂÖеÄһЩÎÊÌ⣬Ôõô°ì
ÒѾÓÐ41È˻ظ´
Éó¸åÒâ¼û·µ»Ø£¬ÓиöÉó¸åÈËÒªÇó²Î¿¼ËûµÄһƪÎÄÕÂ
ÒѾÓÐ10È˻ظ´
ÎÄÕµÄÉó¸åÒâ¼û£¬´ó¼Ò°ïæ¿´¿´£¡
ÒѾÓÐ6È˻ظ´
Éó¸åÖз¢ÏÖ×÷ÕßһƪÏàËÆ¶È¼«¸ßµÄÎÄÕÂÒѾÔÚÁíÒ»ÆÚ¿¯ÔÚÏߣ¬¸ÃÔõô°ì£¿
ÒѾÓÐ63È˻ظ´
·¢½ð±ÒÇóÖú ÀÏʦÈÃÎÒ°ÑÎÄÕÂÖ±½Ó·¢¸øÉó¸åÈË Óʼþ¸ÃÔõôд
ÒѾÓÐ8È˻ظ´
TalantaÎÄÕ±»¾Ü£¬µ«Çë¸÷λ°ïÎÒ¿´¿´ÕâÑùµÄÉó¸åÒâ¼ûÊÇʲôÒâ˼
ÒѾÓÐ15È˻ظ´
ºÜÓÐȤ£ºµ±Reviewer±ä³ÉÎÄÕµĺÏ×÷Õßʱ£¬ÈçºÎ»Ø¸´ËûµÄÉó¸åÒâ¼û£¿Çë¸ßÈËÖ¸µã£¬Ð»Ð»£¡
ÒѾÓÐ35È˻ظ´
±à¼·¢´íÉó¸åÒâ¼û£¬µ«ÎÄÕÂÎÞ½øÕ¹£¬ÈçºÎ´¦Àí
ÒѾÓÐ9È˻ظ´
ÎÒ¸ø¹úÍâÆÚ¿¯ÎÄÕµÄÉó¸å½á¹ûºÍÉó¸åÒâ¼û
ÒѾÓÐ178È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
2026½Î÷¿Æ¼¼Ê¦·¶´óѧÉêÁÁ×éÕÐ˶ʿÑо¿Éú
+1/91
Çൺ¿Æ¼¼´óѧÉúÎ﹤³ÌѧԺÕе÷¼Á˶ʿÑо¿Éú
+1/71
Ìì½ò¿Æ¼¼´óѧ-£¨ÔºÊ¿ÍŶӣ©ÏȽøÏËάÓëÖ½»ù¹¦ÄܲÄÁÏÍÅ¶Ó ÕÐÊÕ˶ʿÉú
+1/41
°²»Õ¹¤³Ì´óѧ»¯Ñ§Óë»·¾³¹¤³ÌѧԺ¶ÔÍâÕÐÊÕ2026¼¶µ÷¼Á˶ʿÑо¿Éú
+1/36
Õã½Ê¡ÈËÃñÒ½Ôº²©Ê¿ºó¸ÚλÕÐÆ¸
+1/33
¹þ¶û±õ¹¤Òµ´óѧ£¨ÉîÛÚ£©-ºÎ×Ô¿ª½ÌÊÚÍŶӳÏÕл¯Ñ§¹¤³ÌÓë¼¼Êõרҵ²©Ê¿Ñо¿Éú
+1/30
Î人·ÄÖ¯´óÑ§È«ÖØË¶Ê¿µ÷¼Á
+1/26
Õã½´óѧ¹âµçѧԺ¡¢¼«¶Ë¹âѧʵÑéÊÒ °¢Ãë·½Ïò ÕÐÆ¸¿ÆÑÐÖúÀí2Ãû
+1/13
ͬ¼Ã´óѧ»·¾³Ñ§Ôº Ð¤Ù»ÌØÆ¸Ñо¿Ô±¿ÎÌâ×é ÕÐÆ¸Ë¶Ê¿/²©Ê¿£¨³¤ÆÚÓÐЧ£©
+1/11
ËÕÖݳõ´´¹«Ë¾³ÏƸ»¯Ñ§¹ý³Ì¹¤ÒÕÓëÓ²¼þϵͳ¹¤³Ìʦ
+1/9
ͬ¼Ã´óѧ»·¾³Ñ§Ôº Ð¤Ù»ÌØÆ¸Ñо¿Ô±¿ÎÌâ×é ÕÐÆ¸Ë¶Ê¿/²©Ê¿£¨³¤ÆÚÓÐЧ£©
+1/6
»¶Óµ÷¼Á±¨¿¼
+1/6
Öйú¿ÆÑ§Ôº´óѧÄÉÃ׿ÆÑ§Óë¼¼ÊõѧԺ-ÂÞñõ¿ÎÌâ×é³ÏÕÐ˶ʿÑо¿Éú
+1/5
½ËտƼ¼´óѧ»úе¹¤³ÌѧԺº£Ñó×°±¸·ÂÉú¿ÎÌâ×éÕÐÉú¼ò½é
+1/4
º¼Öݵç×ӿƼ¼´óѧ ´Åµç¹¦ÄܲÄÁÏ´´ÐÂÍÅ¶Ó ÕÐÊÕ˶ʿµ÷¼ÁÉú
+1/4
ÕÐÊÕ´ÓÊÂ´óÆø¸´ºÏÎÛȾ³ÉÒòÁìÓòÑо¿Éú
+1/3
5¿Æ´óÕÐÊÕ²ÄÁÏרҵ˶ʿ
+1/3
CD40L¿¹ÌåÈçºÎµ÷¿ØÃâÒßÓ¦´ð£¿
+1/3
ÉϺ£Ê¦·¶´óѧÓлú»¯Ñ§×¨ÒµÑо¿ÉúÕÐÉú
+1/2
¹ã¶«¹¤Òµ´óѧ»·¾³¿ÆÑ§Ó빤³ÌѧԺÕÐÊÕ×ÊÔ´Óë»·¾³×¨Òµ²©Ê¿Ñо¿Éú
+1/1
chuzhufei
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- SEPI: 5
- Ó¦Öú: 105 (¸ßÖÐÉú)
- ¹ó±ö: 0.001
- ½ð±Ò: 5829.3
- Ìû×Ó: 2608
- ÔÚÏß: 1857.6Сʱ
- ³æºÅ: 706214
5Â¥2011-03-09 16:37:07
2Â¥2011-03-09 16:09:59
visitor958
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 2283 (½²Ê¦)
- ¹ó±ö: 0.05
- ½ð±Ò: 17310
- Ìû×Ó: 15735
- ÔÚÏß: 2926.6Сʱ
- ³æºÅ: 489254
3Â¥2011-03-09 16:14:09
4Â¥2011-03-09 16:35:48














»Ø¸´´ËÂ¥